Fungal Infections in Non-neutropenic Patients
A special issue of Journal of Fungi (ISSN 2309-608X). This special issue belongs to the section "Fungal Pathogenesis and Disease Control".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 309
Special Issue Editors
Interests: nosocomial infections; invasive fungal disease; aspergillosis; antifungal/antimicrobial stewardship; COVID-19
Special Issues, Collections and Topics in MDPI journals
Interests: infection; fungi; resistance; intensive care medicine; systemic mycosis; invasive fungal infection; candidiasis; antifungal treatment regimens
Special Issue Information
Dear Colleagues,
The increasing incidence of systemic fungal infections in general wards and in critical care units is directly related to the growing number of immunocompromised individuals due to aging, cancer chemotherapies, autoimmune disorders typically treated with immunosuppressive drugs, critical illnesses, and other aspects, resulting in superficial, deep, and systemic mycoses. Aspergillosis, Mucormycosis, Candidiasis, Cryptococcosis, fungal neglected tropical diseases (chromoblastomycosis, paracoccidioidomycosis), and AIDS-related mycoses account for superficial, deep, and systemic mycoses, while Candida auris is considered a serious global health threat. Additionally, the emergence of triazole and echinocandin resistance complicated the selection of an appropriate antifungal treatment. Fungal dose optimization is closely related to successful therapeutic management that might overcome certain types of antifungal resistance. Therefore, the establishment of antifungal stewardship programs, especially in immunocompromized non-neutropenic patients in any clinical setting, is of the utmost importance.
The aim of this Special Issue is to cover multiple aspects of fungal dose optimization, risk factors for systemic mycoses, epidemiological aspects, and several fungus-related clinical challenges. Authors with research interests and expertise in this topic are invited to contribute in order to enhance the knowledge in this area and improve its clinical management.
Dr. Eleni Magira
Dr. Olga Kampouropoulou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epidemiology
- systemic emerging mycoses
- antifungal resistance
- antifungal stewardship
